Deciphering the roles of eosinophils and T lymphocytes in EGID

解读嗜酸性粒细胞和 T 淋巴细胞在 EGID 中的作用

基本信息

  • 批准号:
    10663530
  • 负责人:
  • 金额:
    $ 19.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-01 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Dr. Fei Li Kuang is an Assistant Professor in the Division of Allergy and Immunology at Northwestern University Feinberg School of Medicine. Her clinical and research interests focus on eosinophilic disorders, including eosinophilic gastrointestinal disorders (EGIDs), inflammatory diseases defined by excessive numbers of GI tissue eosinophils as result of an inappropriate prolonged Th2 response to food antigens. Both eosinophilic esophagitis (EoE) and non-esophageal EGIDs such as eosinophilic gastritis/duodenitis (EG/EoD) are associated with significant morbidity and have a profoundly negative impact on quality of life. When untreated, there is progressive scarring of the affected GI tract segments that is not easily reversible. While both eosinophils and specialized Th2 cells are implicated in EGID pathogenesis, numerous questions remain as to their precise roles. This application proposes to focus on what is different about eosinophils in EGID as compared to myriad number of other eosinophilic disorders accompanied by excessive blood eosinophilia. Similarly, specialized Th2 cells are invoked to be biomarkers of disease in IgE-mediated disorders such as food allergy and allergic rhino-conjunctivitis, which are markedly different allergic diseases from EGID, so what makes these cells different in EGID will also be examined. This career development award, under the mentorship of Dr. Bruce Bochner, focuses on investigating the cellular and molecular mechanisms of EGID pathogenesis. to advance the understanding of this disease process. Dr. Kuang has preliminary evidence suggesting that there are unique blood eosinophil signatures in EGIDs that distinguish them from blood eosinophils in other eosinophilic disorders, and that specialized circulating Th2 cells in EGIDs differ from those identified in more traditional IgE-mediated atopic conditions, and that quantitative and qualitative changes in both cell types track with response to therapy and disease remission. The central hypothesis of this proposal is that unique blood eosinophil and T lymphocyte signatures define EGID as a clinical entity distinct from other eosinophilic disorders or food- triggered diseases. This will be addressed by 3 non-overlapping but complementary aims: 1) Definition of unique blood eosinophil signatures in EGID that distinguish it from other eosinophil-associated disorders or atopic disorders with blood eosinophilia; 2) Precise identification of the specialized Th2 cells in EGID as compared to food allergy; 3) Evaluation of the effect of dietary and steroid treatment on blood eosinophil and specialized Th2 lymphocyte signatures in EGID This innovative study will use novel data generated by Dr. Kuang to further investigate areas of EGID that are currently poorly understood. Importantly, this award will provide Dr. Kuang with additional career development and training needed to build her own successful research team, establish independence from her mentor and significantly advance her career studying EGID pathogenesis.
抽象的 Fei Li Kuang博士是西北地区过敏和免疫学系的助理教授 大学费恩伯格医学院。她的临床和研究兴趣专注于嗜酸性疾病, 包括嗜酸性胃肠道疾病(EGID),由过度定义的炎症性疾病 由于对食品抗原的长时间反应,胃肠道嗜酸性粒细胞的数量是由于不适当的。 嗜酸性食管炎(EOE)和非食道食管,例如嗜酸性胃炎/十二指肠炎 (例如/EOD)与明显的发病率有关,并对生活质量产生深远的负面影响。 如果不进行治疗,就会有受影响的胃肠道段的渐进性疤痕不易可逆。 虽然嗜酸性粒细胞和专业的Th2细胞都与egid发病机理有关,但许多 关于它们的确切角色仍然存在问题。本申请建议专注于不同的 与无数其他嗜酸性疾病相比 血液嗜酸性粒细胞增多。同样,专门的TH2细胞被引用为疾病的生物标志物 IgE介导的疾病,例如食物过敏和过敏性犀牛 - 连接性炎,它们明显不同 EGID的过敏性疾病,因此还将检查这些细胞在EGID中的不同之处。 在布鲁斯·博切纳(Bruce Bochner)博士的指导下,该职业发展奖的重点是调查 EGID发病机理的细胞和分子机制。促进对这种疾病的理解 过程。 Kuang博士有初步证据表明存在独特的血液嗜酸性标志 在将它们与其他嗜酸性疾病中的血液嗜酸性粒细胞区分开的egid中 EGID中的循环Th2细胞与在更传统的IgE介导的特征条件下鉴定的细胞不同, 以及两种细胞类型的定量和质量变化,都可以反应治疗和疾病 缓解。该提议的中心假设是独特的血嗜酸性粒细胞和T淋巴细胞 特征将EGID定义为与其他嗜酸性疾病或食物不同的临床实体 触发疾病。这将通过3个非重叠但互补目的来解决:1)定义 EGID中独特的血液嗜酸性粒细胞特征,将其与其他嗜酸性粒细胞相关 血液嗜酸性粒细胞的疾病或特应性疾病; 2)精确鉴定专业的TH2细胞 与食物过敏相比,在Egid中; 3)评估饮食和类固醇治疗对血液的影响 Egid中的嗜酸性粒细胞和专门的Th2淋巴细胞特征 这项创新的研究将使用Kuang博士生成的新数据来进一步研究Egid的领域 目前了解不足。重要的是,该奖项将为Kuang博士提供其他职业 建立自己成功的研究团队所需的发展和培训,建立独立于 她的导师并大大提高了她研究埃奇发病机理的职业。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

相似国自然基金

NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
  • 批准号:
    82370796
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
  • 批准号:
    82103851
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
自主要求剖宫产对子代工作记忆的影响及低位GCs与海马CRH-CRHR1信号互作机制
  • 批准号:
    81872630
  • 批准年份:
    2018
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
应用H295R细胞研究SF-1、ACTHR对肾上腺皮质激素分泌调控的影响机制
  • 批准号:
    81200579
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
  • 批准号:
    10820331
    10820331
  • 财政年份:
    2023
  • 资助金额:
    $ 19.1万
    $ 19.1万
  • 项目类别:
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease
关节内药物递送调节炎症性关节疾病中的免疫细胞
  • 批准号:
    10856753
    10856753
  • 财政年份:
    2023
  • 资助金额:
    $ 19.1万
    $ 19.1万
  • 项目类别:
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
  • 批准号:
    10600887
    10600887
  • 财政年份:
    2023
  • 资助金额:
    $ 19.1万
    $ 19.1万
  • 项目类别:
Toward therapeutic targeting of liquid-liquid phase separation dynamics in skin
皮肤液-液相分离动力学的治疗靶向
  • 批准号:
    10679610
    10679610
  • 财政年份:
    2023
  • 资助金额:
    $ 19.1万
    $ 19.1万
  • 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
  • 批准号:
    10649012
    10649012
  • 财政年份:
    2023
  • 资助金额:
    $ 19.1万
    $ 19.1万
  • 项目类别: